Biagon Inc.
Biagon Inc. is a biotechnology company focused on leveraging machine learning to discover and design biased agonists for GPCR targets. Their first-in-class algorithm offers a novel approach to exploit cell signaling for therapeutic development across a range of indications, including heart failure and neurodegenerative diseases. The company is driven by a passion for opening therapeutic windows through internal and partnered programs.
Biagon Inc.
Biagon Inc. is a biotechnology company focused on leveraging machine learning to discover and design biased agonists for GPCR targets. Their first-in-class algorithm offers a novel approach to exploit cell signaling for therapeutic development across a range of indications, including heart failure and neurodegenerative diseases. The company is driven by a passion for opening therapeutic windows through internal and partnered programs.